United Kingdom Liver Cancer Therapeutics Market is expected to reach US$ 13.16 billion by 2033 | Top key players - AstraZeneca, Bayer AG, Eli Lilly.

Market Size and Forecast:

The Liver Cancer Therapeutics Market Size reached US$ 3.36 billion in 2024, and is expected to reach US$ 13.16 billion by 2033, growing at a CAGR of 16.5% during the forecast period 2025-2033.

The Liver Cancer Therapeutics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/liver-cancer-therapeutics-market?sz

The Liver Cancer Therapeutics Market refers to the global industry focused on the development, manufacturing, and commercialization of treatments targeting liver cancer. It encompasses pharmaceuticals, targeted therapies, immunotherapies, and novel biologics aimed at improving patient outcomes, reducing tumor progression, and enhancing survival rates. Market growth is driven by rising liver cancer prevalence, technological advancements, and increasing healthcare investments.

Industry Recent Developments:

USA:
In April 2025, the FDA approved a dual-checkpoint immunotherapy combination of nivolumab plus ipilimumab as a first-line treatment for advanced hepatocellular carcinoma (HCC) patients.

In July 2025, North America saw accelerated approvals of immune checkpoint inhibitors like pembrolizumab and nivolumab, with clinical trials showing improved survival rates for liver cancer patients.

Japan:
As of mid-2025, growth in reimbursements for transarterial chemoembolization with immuno-oncology (TACE-IO) protocols is driving the market, with the impact expected in the medium term (2-4 years).

In October 2025, Gunze Medical and HistoSonics entered an exclusive distribution agreement for a noninvasive sonic beam therapy platform utilizing histotripsy technology to treat liver tumors including hepatocellular carcinoma.

Europe:
The European market is expected to grow steadily, driven by technological advancements and increasing adoption of minimally invasive cancer treatments, with Germany and France showing the highest growth rates as of 2025.

The United Kingdom leads the market, supported by better knowledge and early diagnosis of liver cancer, and increasing new liver cancer cases contributing to market growth in 2025.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/liver-cancer-therapeutics-market?sz

Major Key Players:

AstraZeneca
Bayer AG
Eli Lilly
Bristol-Myers Squibb Company
Eisai Co., Ltd.
Genentech.

Key Growth Drivers:

Surge in the incidence of hepatocellular carcinoma (HCC), especially in regions like Asia-Pacific and Sub-Saharan Africa, contributing significantly to long-term market growth.

Approved first-line dual checkpoint immunotherapy combinations, such as nivolumab plus ipilimumab, which have improved treatment outcomes and expanded therapy options in North America and the EU.

The rising prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in obese populations, particularly in North America, the EU, and the Middle East, driving demand for targeted treatment modalities.

Segments Covered in the Liver Cancer Therapeutics Market:

By Type: Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Others.

By Therapy: Chemotherapy, Immunotherapy, Targeted Therapy, Others.

By Route of Administration: Oral, Intravenous.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=liver-cancer-therapeutics-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Liver Cancer Therapeutics market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Liver Cancer Therapeutics Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Liver Cancer Therapeutics market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Liver Cancer Therapeutics Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Liver Cancer Therapeutics Market in 2025?
◆ What is the projected growth rate of the Liver Cancer Therapeutics Market through 2033?
◆ Who are the key players in the Liver Cancer Therapeutics Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.